Our Parkinson's Place

WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Friday, November 15, 2013

NEW DRUG FOR PARKINSON'S DISEASE PSYCHOSIS

2th November 2013 - New research

Lancet [2013] Oct 31 [Epub ahead of print] (J.Cummings, S.Isaacson, R.Mills, H.Williams, K.Chi-Burris, A.Corbett, R.Dhall, C.Ballard)

Parkinson's Disease psychosis, which includes hallucinations and delusions, is frequent and debilitating in some people with Parkinson's Disease. Pimavanserin, which is a serotonin 5-HT2A inverse agonist that is presently being assessed, aims to treat Parkinson's Disease psychosis. A clinical trial assessed the effect of Pimavanserin. 

They took 40mg pimavanserin per day. The primary measure was the antipsychotic benefit using the Parkinson's disease-adapted scale for assessment of positive symptoms (SAPS-PD). According to the Parkinson's disease-adapted scale for assessment of positive symptoms (SAPS-PD) those people taking pimavanserin reduced their score by 5.79 compared with a reduction of 2.73 by those taking a placebo. Over 10% of the patients discontinued because of an adverse event. However, in previous clinical trials there was either no effect or it was beneficial for some but not all measures of psychosis
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)